INTRODUCTION
Bacteria in their natural environment are faced with predation by both macro-and microorganisms. Some of the more important of the predators are the bacteriophages, and bacteria have evolved means of beating off viral attackers at almost all stages of the phage life cycle. The most effective defense is to prevent any productive contact between the phage and the bacteria. This can be done by mutation of phage receptors in the cell wall or, possibly more effectively, by the secretion of a barrier that prevents the approach of the phage, such as a capsule or slime layer. In one documented case, the next stage of the viral infection is blocked; that is, the virus can absorb to its receptor on the cell wall, but is unable to inject its deoxyribonucleic acid (DNA) (32, 112, 113) . Once the DNA has been injected into the cell, survival of the bacterium by at least two different mechanisms is still possible. If some component of the host is not suited to the needs of the bacteriophage the infection will be abortive at different stages of t Address reprint requests to D. H. Kriger. intracellular phage development; finally, DNA restriction enzymes in the host may destroy the DNA.
The phage, for its part, can adapt to such resistant or nonpermissive cells by mutation; for instance, it can overcome the cells' resistance by a host range mutation which alters its adsorption specificity. Furthermore, it is known that bacteriophages can become adapted to their host cells by host-controlled modification; depending on the cell which last served as host, the virus carries a specific modification so that the ability to replicate in cells of the same strain is improved, but the ability to replicate in cells of a different strain is restricted. Such modifications are characterized by the reversibility of the phenotypic change by one growth cycle of the virus in another host strain and are thus distinguished from mutation (82) (Fig. 1) .
Authentic restriction-modification systems, according to the criteria first described by Luria (82) and outlined in Fig. 1 , have been thoroughly investigated in Escherichia coli, Bacillus subtilis, Haemophilus spp., and Salmonella spp. (for recent reviews, see references 9 and 33). They have also been described in Corynebacterium is restriction and modification negative, the reversibly changeable growth of the virus is only manifest on the other cell strain (Y); plating on X is not altered. In the figure the efficiency of restriction is about 10-fold; that is, the titer on the restricting host is about 101 of that on the nonrestricting host. Measured efficiencies vary with the phage and restriction system from barely detectable to about l0-5. diphtheriae, Pseudomonas aeruginosa, Rhizobium leguminosum and Rhizobium trifolii, Shigella sonnei, Streptococcus spp. Staphylococcus aureus, Streptomyces albus, and Streptomyces hygroscopicus (8, 11, 18, 33, 66, 97) .
The "classical" mechanism of restriction and modification of bacteriophages consists of endonucleolytic cleavage (restriction) of phage DNA when it is not specifically methylated (modified) at certain sites (9, 11, 33, 88, 91, 92, 108, 130, 133) . After one growth cycle in a particular host, the viral DNA is methylated at the recognition sites specific for the DNA host specificity system of that host and is protected in this way when infecting cells possessing the same DNA restriction-modification system. The host-controlled DNA modification is the main way to overcome DNA restriction. However, when a phage is infecting a cell with a different DNA restriction-modification system, the phage DNA is restricted because it is not methylated in the DNA sequences recognized by the new system. The restriction and modification processes affect not only phage DNA but also, as a rule, any intracellular DNA.
Meanwhile, we have learned that phenotypic restriction and modification of bacterial viruses ( Fig. 1) can also occur by a mechanism that involves protein modification rather than reactions at the DNA level. In this way, the ability of a phage to adsorb to a new host cell is influenced by a modification of phage conferred to it by the previous host cell (70, 71 ; for a review, see reference 77). Figure 2 represents the different mechanisms connected with the phenomenon of host-controlled restriction and mo4ification.
Most species and strains of bacteria that have been examined contain endonucleases with the properties expected of restriction enzymes; that is, they give sequence-specific DNA cleavage, indicating the importance of restriction for bacteria. The involvement of most of these enzymes in an authentic restriction-modification system has not been demonstrated (for most, it has not even been examined); some of them may have other functions such as in recombination or repair of pathways.
Bacteriophages have learned to live with the restriction systems of their hosts by developing a wide range of different mechanisms for avoiding the worst effects of restriction. Antirestriction mechanisms of one kind or another have been found in practically every phage that has been examined, and in this review we describe the mechanisms that are used by the bacteriophages of B. subtilis and E. coli.
DNA RESTRICTION-MODIFICATION ENZYMES
Three broad groups of restriction-modification systems can be discerned that differ from each other in the complexity of the enzyme structures and reaction mechanisms and in the kinds of DNA sequences that are recognized. The major characteristics of these three groups are described in Table 1 . The vast majority of the known enzymes are of type II. This is because these are the enzymes that recognize simple, generally symmetrical, sequences and that cut the DNA in a fixed position relative to their recognition sequence. They are the enzymes that have revolutionized biology during the last decade by the possibilities that they offer for gene cloning and DNA analysis; in consequence, many genera and species of bacteria have been systematically screened for their presence. These screening procedures are relatively easy; the enzymes give well-defined and characteristic DNA fragments that can be recognized after agarose or polyacrylamide gel elec- 47, 1983 related to each other. Again, the major region of nonhomology between the two systems is found in the gene coding the subunit that recognizes the specific sequences (43, 56) . (For recent reviews on type I and III restriction systems, see references 9, 33, and 133). The extraordinary diversity of restriction enzymes documented above means that it is unlikely that a bacteriophage can develop equally effective mechanisms for combatting all of the enzymes that it is likely to encounter in its hosts. Furthermore, many bacterial strains produce more than one enzyme, and the kinds of enzymes produced may change with time as some systems are lost by mutation and new ones are acquired through processes such as conjugation or transduction.
INHIBITION OF RESTRICTION ENZYMES
BY VIRAL PROTEINS ocr Gene Product of Phages T3 and T7 The most thoroughly investigated example of active antirestriction is that exerted by the closely related phages T3 and T7. It has long been known that T3 and T7 can be passaged through E. coli strains with different DNA host specificities (for example, E. coli B and K-12) without being phenotypically restricted (34 (77, 78) . In this review we will use the name ocr, which stands for "overcome classical restriction." Since the basic discovery that ocr-mutants are unable to replicate when they are passaged between E. coli K-12 and B hosts (118, 119) , the protection mechanism has been extensively studied. It was shown that the ocr gene product of T3 has two different phenotypes: Ocr itself, and Sam, the ability to hydrolyze intracellular SAM (77, 78 (78) .
The ocr protein synthesized in virus-infected cells counteracts the type I systems EcoK and EcoB (67, 78, 118, 119) , the related Salmonella systems SA and SB (69) , and type III (EcoPl) systems (73) (74) (75) . It is also active in vivo against the unclassified EcoRIII enzyme (D. H. KrUiger and L. S. Chemin, unpublished data) coded by the plasmid R124 (5, 53, 115) . The inhibition does not depend on SAM hydrolysis, but intervenes at a later step in the interaction between the restriction endonuclease and the modification methylase preventing both DNA cleavage and methylation (73, 77) . The type II restriction enzymes such as EcoRV are not blocked by the ocr gene product: T3 DNA has five EcoRV sites and is restricted both in vivo and in vitro (T7 DNA has no EcoRV sites) (76) . Using T3 mutants that had acquired an EcoRI site, Miyazaki et al. showed that ocr is also ineffective against this type II enzyme (90) .
The effect of the ocr protein is to actively inhibit the cellular restriction enzyme, thus protecting the unmodified recognition sites in the phage DNA against cleavage. This protection is, moreover, extended to any other foreign DNA simultaneously introduced into the cells. When T3 or T7 are heavily irradiated with UV light so that they are unable to replicate and lyse the cells, but are still able to express the ocr gene, it is possible experimentally to introduce plasmid DNA into the cells by conjugation (67) or transformation (71, 104) without it being restricted. The recipient cells survive and replicate their own as well as the newly acquired plasmid DNA (for a review, see reference 77).
Completely independently of SAM hydrolysis, the ocr protein of T7 and sam-T3 mutants also prevents host-controlled modification (68, 75; I. G. Bogdarina, M. Reuter, Y. I. Buryanov, and D. H. KrUiger, submitted for publication).
In vitro studies with the purified ocr protein from both T3 and T7 have confirmed the distinction between the Ocr and Sam phenotypes of the T3 protein (117) , the lack of activity against type II restriction enzymes (76, 85) and the blocking of both the endonucleolytic (85, (75, 77) .
Restriction enzymes normally cleave foreign DNA immediately after its entry into the cell (30) . How, then, can the ocr gene product appear early enough during the infection to block the restriction enzymes, especially since it has been shown that protection of the DNA depends on de novo protein synthesis in the infected cell (111; D. H. Kruger, unpublished data)? A delayed injection of phage DNA into the cell may be the "trick" by which the virus prevents exposure of DNA recognition sites before the appearance of ocr protein and the blockage of the cellular restriction enzyme (77) . The phage first injects the left end of its genome, which contains the ocr gene; transcription of this region of the genome is a prerequisite for the injection of the rest of the DNA (Fig. 3) . Support for this idea comes from experiments that showed that injection of T7 DNA into E. coli is blocked by the transcription inhibitors rifampin and streptolydigin (136) at the position 11.9% and that no EcoK site is found in the sequence of the left 30o of the T7 genome (29) . The ocr gene itself is situated between positions 2.3% and 3.2% from the left end of the 17 genome (29) . The development of the antirestriction function or functions of phage T5 seems to follow a similar schedule (see below).
Inhibitor Produced by Bacillus Phages 4NR2rH and 4lrH
In Bacillus amyloliquefaciens producing the BamNx type II restriction enzyme, the phages 4NR2rH and 41rH are not restricted despite the fact that their DNA contains sites for this enzyme (83, 84) . Both phages produce a protein that blocks the BamNx enzyme. The protein coded by 41rH has been isolated; it has a molecular weight of 20,000 and is an inhibitor of BamNx, but not of any other enzyme tested, including even AvaIl, which recognizes the same DNA sequence as BamNx (84) .
These two phages provide the first examples of an active viral block of a type II restriction enzyme. They were originally described as mutants since their parental phages are sensitive to BamNx (83, 84) . However, the high frequency with which BamNx-resistant mutants appeared in the population (10-4) makes it more likely that they arise by processes other than mutation, perhaps by DNA rearrangements similar to those that control the expression of different host range genes in phage Mu (19) or that they represent the original virus type which was "overgrown" in the laboratory under nonselective conditions by mutants that had lost the antirestriction property.
VIRUS-CODED DNA MODIFICATIONS
Site-Directed DNA Methylation by Some Bacillus Phages The restriction endonuclease R.BsuRI of B. subtilis cuts the sequence 5'-GGCC-3' (13) if the central cytosine is not methylated by the corresponding methylase, M.BsuRI (42) . However, in certain restriction-and modification-negative B. subtilis strains a DNA methyltransferase with the same sequence specificity as M.BsuRI is inducible (41) . This enzyme is prophage coded and is not expressed in stable lysogens (60) . Such specific methylase genes were found to be carried by the phages SPP (129) and 43T (20, 99) . It is important to note that these genes are expressed not only after induction of prophage but also during lytic infection, so that the DNA in phage particles produced by either route is VOL. 47, 1983 on January 18, 2018 by guest http://mmbr.asm.org/ Downloaded from modified. In this way the phage protect their own DNA, and also heterologous DNA, against restriction in BsuRI-coding cells (60, 99, 127) . Since restriction enzymes recognizing the sequence GGCC are demonstrable in several strains of B. subtilis and other Bacillus species (see also Table 3 ), this methylation could allow the spread of phage to many different potential hosts.
Recently it was shown that the SPP used in the studies cited above (60, 127) differs from the original SP, phage, and it has now been renamed SPR (98) . A comparative study demonstrated that the phages SPR, 43T, SP,, and pll are all insensitive to restriction in BsuRI-coding cells because of their DNA self-methylation. The methyltransferase genes of the different phages are interchangeable. No homology was found between these phage genes and B. subtilis chromosomal DNA which codes for M.BsuRI (98) . The (124, 125) . The mom gene was located on the P segment of the Mu genome (126) , and it is expressed at a higher level after prophage induction than before infection (124, 125) . Protection results from a mom-specific modification of DNA which also acts in trans so that not only the Mu DNA itself, but also any other DNA present in the cell (i.e., superinfecting X phage), is modified (124, 125) . However, the mom-directed DNA modification does not consist of a MICROBIOL. REV. methylation, but is an acetimidation of the N6 position of about 15% of the adenine residues in DNA (46-48; S. Hattman, personal communication; R. Kahmann, personal communication).
It is still unknown how the Mom function manages the conversion of adenine to the modified base N6-(1-acetamido)adenine. The mom protein has not been characterized or purified. Recent in vitro studies have shown that the Mu mom' DNA is at least partially resistant to the action of several type II restriction endonucleases, whereas Mu mom-DNA is sensitive. By comparing and aligning the recognition sequences of restriction enzymes whose cleavage is affected by the Mom function, we deduced a consensus recognition sequence for Mom of 5'-C/G-A-G/C-N-Py-3' (63). By checking the recognition sequences of E. coli restriction enzymes (Table 1) 
For the self-modification of phage not only the mom gene function, but also the cellular adenine (dam) methylase, is necessary (65, 125) . However, the sole function of dam appears to be that of stimulating transcription of mom by methylating specific DNA sequences upstream of the mom gene (49, 101) .
The first indication of a positive correlation between DNA methylation and gene expression in procaryotes was the finding that nonmethylated T3 genomes are not expressed in starved cells (72, 77) . The regulation of mom gene expression is a more specific example of this. The situation in procaryotes therefore seems to be the opposite of that obtained in higher eucaryotes where methylation (formation of 5-methylcytosine) at specific sites in the genome can inhibit gene expression (for reviews, see references 28, 31, and 102).
DNA Adenine Methylase of Phage T2
The T-even phages T2, T4, and T6 are naturally resistant to all of the restriction systems that they encounter in their hosts because their DNA contains an unusual base and is, in addition, post-synthetically modified by glucosylation (see below). Phages' T2 and T4 (but not T6) also code for a DNA-adenine methyltransferase that methylates a fraction of the adenine residues in the phage DNA to 6-methylaminopurine (37) . Perfectly viable mutant phages can be found in which the postsynthetic glucosylation does not occur. These mutant phages are still protected against most of the restriction systems of their hosts, the exception being the type III EcoPl system; phages containing non-glucosylated DNA are restricted in P1 lysogens expressing EcoPl (106) .
Mutations of phage T2 have been found that are partially protected against P1 restriction even though their DNA is still not glucosylated (106) . These mutants were found to have an altered DNA-adenine methyltransferase which methylated about two to three times more of the adenines in the phage DNA than did the wildtype enzyme (45) . There is some disagreement in the literature regarding the sequences recognized by these enzymes (14, 51) . However, it is most likely that the wild-type methylase methylates the adenosine residue in the sequence 5'-G-A-T-3', whereas the mutant that provides protection against EcoPl recognizes both 5'-G-A-T-3' and 5'-G-A-C-3' (for a discussion of this, see reference 48) . This relaxed specificity of the mutant enzyme immediately explains why it affords protection against EcoPl, because the recognition sequence for EcoPl (5'-A-G-A-C-C-3', see Table 1 ) contains the 5'-G-A-C-3' sequence and EcoPl modification methylates the central A residue (4, 50) .
This example of antirestriction may seem rather artificial, because the phage must first carry mutations in the genes for the glucosylases to make them sensitive to EcoPl, and then a further mutation in the methylase is needed to generate the antirestriction activity. However, this scheme, even though it was carried out in the laboratory, affords a fascinating glimpse of the way in which antirestriction processes may have evolved in nature and the flexibility of the bacteriophage response to challenge by a restriction system to which it was not previously susceptible.
DDVI-Coded Guanine Methylase
In cells infected by phage DDVI, an enzyme that methylates the 7 position of guanine and modifies about 0.25% of the guanine bases in the phage DNA, was detected (96) . This is a very unusual result, since 7-methylguanine is known to be a very unstable constituent of DNA (48, 87) . Even when phage DDVI is grown in E. coli B cells, DDVI DNA lacks 6-methylaminopurine (the product of the EcoB host specificity methylation), but it is not restricted in these cells (96) . Nikolskaya et al. concluded that the 7-methylguanine residues could protect the phage DNA against EcoB restriction (96) . On the other hand, it was earlier shown that DDVI DNA contains the unusual base 5-hydroxymethylcytosine (HMC), which is further modified by glucosylation (95) , and DNA with this structure is resistant to EcoB restriction (see below).
STIMULATION OF HOST MODIFICATION
FUNCTIONS Bacteriophage X and a few other lambdoid phage encode a most unusual antirestriction function, specific for type I systems, that operates not by inhibiting restriction, but by stimulating the modification reaction (135) . The function is coded by the ral gene, which maps in the major leftward early operon of the phage between the genes cIIl and N (135). The ral gene product has never been identified; however, the DNA sequence of this region of the X genome predicts that ral should be a small protein of molecular weight 7,600 (58, 110) . The ral function is active only against type I restriction systems, and its effects are seen not on the primary infection of a restricting host where restriction is normal, but upon reinfection of the same host strain with the progeny from the first infection; ral+ phages are fully modified, whereas ralt phages are only partially modified and plate with low efficiency. The ral effect is readily understandable in terms of what we know about the reaction mechanism of type I modification enzymes. These enzymes methylate fully unmodified DNA very slowly, their best template being DNA that already contains a methyl group in one of the two strands of the recognition sequence (16, 128) . Such hemimethylated DNA is, of course, generated in cells by the normal processes of DNA replication and repair. The effect of ral would be to stimulate the enzymes to methylate nonmodified DNA faster. Unfortunately, it has not been possible to isolate the ral protein so that this hypothesis could be tested in vitro (K. Ineichen and T. Bickle, unpublished results).
The ral gene product has also been reported to interact with other ATP-dependent nucleic acid enzymes of E. coli, including the transcription termination factor rho. It inhibits the activity of this factor leading to a phenotypic antitermination activity which, unlike the action of the X N gene product, is not promoter specific (23).
UNUSUAL BASES IN PHAGE DNA
We define as unusual DNA bases all those bases which are not adenine, cytosine, guanine, or thymine and which are synthesized at the level of nucleotide metabolism. These are to be contrasted with the modified bases, which are made by the addition of adducts to bases after DNA replication (postsynthetic DNA modification).
B. subtilis Phages Many B. subtilis phages contain unusual bases in their DNA; e.g., in phages SPOl, SP8, SP82G, +25, +e, and 2C, thymine is completely VOL. 47, 1983 on January 18, 2018 by guest http://mmbr.asm.org/ 352 KRUGER AND BICKLE replaced by 5-hydroxymethyluracil, and in phages PBS1 and PBS2 thymine is completely replaced by uracil. Other cases of the occurrence of unusual bases are also known (for reviews see references 54 and 129). Using (e and PBS2 DNA, Berkner and Folk (7) have undertaken studies on the influence of unusual bases in phage DNA on the cleavage activity of different restriction endonucleases. They found that the influence of the base exchange depended in part on the sequence specificity of the restriction enzymes and in part on the particular enzyme: different enzymes recognizing the same sequence were affected to different extents. Huang et al. (55) have done similar, but more extensive, studies with 30 different restriction enzymes and the following highly substituted DNA molecules: B. subtilis phages PBS1 and SPOt DNAs (described above); DNA from the phage SP15, in which some 60%o of the thymine residues are replaced by 5-dihydroxypentyluracil, which is also glucosylated and phosphoglucuronated post-synthetically; HMC-containing DNA from the Xanthomonas oryzae phage XP12; and DNA from the coliphage T4, which contains glucosylated HMC (see below). All of these DNAs were refractory to cleavage by most of the enzymes, although slow cleavage was reported for some. An exceptional enzyme was TaqI from Thermus aquaticus, which could cleave all of the DNAs to some extent.
It can be concluded that the occurrence of unusual bases in the DNA of B. subtilis phages prevents the action of certain restriction endonucleases and thus protects the phage DNA against cleavage in host cells carrying the appropriate restriction systems. In addition, the unusual bases are expected to fulfill other biological functions, for instance, transcription and replication regulation or DNA conformation and packaging (129) .
Uracil is occasionally produced in normal DNA by spontaneous deamination of cytosine. This potentially mutagenic lesion is normally removed by an enzyme called uracil-N-glycosylase, which cleaves the N-glycosidic bond (81) . Phages like PBS2, whose DNA normally contains uracil instead of thymine, direct the synthesis of a protein that inhibits the host uracil Nglycosylase (35, 62, 63, 123) . The evolution of such an inhibitor demonstrates the importance of the unusual base uracil for the phage.
Hydroxymethylcytosine in T-Even Phage DNA
The T-even phages of E. coli (and also phage DDVI of Shigella sonnei [95] ) contain DNA in which cytosine is completely replaced by the unusual base HMC (132) . The HMC residues are, in addition, glucosylated. As with the B. subtilis phages discussed above, the unusual base is made as a precursor and is incorporated into DNA during replication or repair.
HMC-containing DNA is resistant to the action of many restriction enzymes in vitro. It is completely resistant to HhaI and HpaII and almost completely resistant (less than 10% cleavage) to the enzymes BamHI, HindII, and HindIll (7, 55) . The susceptibility to the enzymes normally found in E. coli will be discussed later.
If phages that replace normal bases by unusual ones do so to protect themselves from host restriction enzymes (see above), the host may respond by evolving nucleases specific for the unusual bases. Such an enzyme can be considered as an "anti-antirestriction mechanism." One such enzyme is found in E. coli, which produces an enzyme that is specific for nonglucosylated, HMC-containing DNA (105) . This enzyme, the product of the rgl genes (rgl for restriction of non-glucosylated DNA), is completely independent of the classical DNA restriction system and cannot in itself be considered a restriction enzyme, because there is no evidence for sequence specificity and no cognate methylation enzyme was found. The classical restriction enzymes and the rgl enzyme coexist in most strains of E. coli, unfortunately, some publications have not sufficiently discriminated between them (e.g., reference 25), a situation that can lead to confusion.
The T-even phages have, in turn, evolved a gene called arn (for anti-restriction endonucleases, again a confusion between restriction enzymes and rgt), which produces an inhibitor of the rgl enzymes. This inhibitor is not effective in preventing rgl destroying the DNA of an infecting T-even phage, probably because it is not made fast enough, but does prevent the action of rgl on a superinfecting phage (26) . The gene has been mapped and cloned in a small plasmid (27) .
These multiple defensive interactions between T-even phages and E. coli indicate that phage and host have had a long evolutionary association. One entirely hypothetical scenario for their evolution is that the phage developed the replacement of cytosine by HMC in their DNA as a response to the presence of restriction enzymes in their host. The host responded by evolving the rgl systems as a specific protection against T-even phages. The phages then evolved two separate means of avoiding the rgl effect: arn, which is relatively inefficient because it will only protect superinfecting phages, and glucosylation. The development of Table 2 . The different kinds of DNA are as follows: wild type (HMC containing and glucosylated); HMC containing, but non-glucosylated; and finally cytosine containing and non-glucosylated (this can be obtained by using a phage carrying multiple mutations [122] ). These differences in restriction in vivo and in vitro suggest that the T-even phages may have additional, as yet undetected, antirestriction functions.
COINJECTION OF PHAGE INTERNAL
PROTEINS AND DNA Phage PI, like all temperate phages, has no unusual bases in its DNA, but it is nevertheless remarkably insensitive to the type I (but not types II and III) restriction enzymes of E. coli. The reason for this is that phage heads contain two different proteins, the products of the nonessential phage genes darA and darB (dar for defense against restriction [S. lida and T. A. Bickle, unpublished data]). When the darA gene is mutated by deletion or transposon insertion, phage particles are produced that contain neither darA nor darB gene products, and these phages are efficiently restricted by the E. coli K-12 B and A restriction systems. When darB is mutated, on the other hand, the phage particles lack the darB gene product, but contain the darA protein. These phages are restricted by the classical type I EcoK and EcoB systems, but not by the aberrant EcoA system. It thus appears that the darA gene protects against EcoA, whereas the darB gene protects against the classical type I systems. The dar systems will protect any DNA from restriction so long as it is packaged within a P1 head. For example, when phage is transduced inside a Pl head, it is protected from restriction. If, however, cells are simultaneously infected with both phage P1 and phage X, the P1 DNA is protected, whereas the A DNA is not. Even dar-phages can be protected against restriction if they are first grown on strains carrying the cloned dar genes; phage particles are produced that contain the dar gene products even though the genome remains dar-, and these particles are protected against restriction in the next round of infection (M. Streiff, S. Iida, and T. Bickle, unpublished data).
The precise mechanism of antirestriction by the dar proteins remains unknown. It seems clear that the proteins are injected into host cells along with the DNA and remain attached to the DNA during the process. The darA gene product is the only one of the two to have been purified, but studies on its mode of action must await the purification of its target enzyme, EcoA.
DESTRUCTION OF RESTRICTION ENDONUCLEASE COFACTORS
The type I and III restriction enzymes require SAM as an essential (type I) or stimulating (type III) effector for stable binding to substrate DNA (Table 1 ). This tight binding is a prerequisite for enzymatic activity. Thus, a depletion of the intracellular pool of SAM, at least for the type I enzymes, should prevent restriction. This has been experimentally demonstrated for the type I enzyme EcoK: cells in which SAM biosynthesis was blocked (by starvation for the precursor, methionine) were defective in restriction (79) . In similar experiments with cells containing type III (or type II) restriction systems, the chromosomal DNA was restricted after long periods of starvation (79) .
These observations are relevant in connection with the SAM hydrolase activity of the phage T3 ocr gene product, which is a very early function in the viral life cycle and destroys the intracellular SAM very soon after infection (37, 52, 77, 117) . Since the sanme protein also inhibits type I enzymes directly by binding to them (the Ocr phenotype, see above), it is not clear whether the SAM hydrolase is necessary for antirestriction. The SAM-activated form of the EcoK restriction enzyme has SAM tightly bound to it; in the presence of DNA, it is very stable, with a half-life of about 6 min, and it is active in the absence offree SAM (134) . Enough of this active enzyme species should survive until the phage DNA has been completely injected, whether or not free SAM is still present in the cell, to ensure efficient restriction. In support of this, one tem- (1, 114) . Perhaps the best-known departure from randomness is seen in the dinucleotide frequencies of the DNA from higher eucaryotes where the sequence 5'-C-G-3' is only found at 1/20 of the expected frequency (61, 120) . One consequence of this is that eucaryotic DNA has remarkably few sites for restriction enzymes that have 5'-C-G-3' in their recognition se (64) . Table 3 shows the expected number and the actual number of sites for some restriction enzymes in the 41 DNA. It is apparent that most of the enzymes for which the low frequency or total absence of sites has been demonstrated can be isolated from Bacillus species or from B. subtilis itself.
In the DNA of Bacillus phage +29 as well, extremely few recognition sites for several restriction endonucleases have been found. For instance, there is no site for BsuRJ, although it would be expected to appear 23 times in 629 DNA. After cloning 4)29 DNA in E. coli the number of cleavage sites does not change, defi- (59) .
A third example is the B. subtilis phage SPO1. On the basis of a random distribution of bases, it would be expected that BsuRI would cleave SPO1 DNA approximately 300 times; however, only five BsuRI cleavage sites were identified (103) . Although the BsuRI recognition sequence 5'-GGCC-3' should not be directly affected by the presence of hydroxymethyluracil instead of thymine in the SPOt DNA (54) , fragments of SPO1 DNA were cloned in E. coli to check this question. Indeed, the substitution of hydroxymethyluracil by the "normal" thymine does not change the low number of BsuRI sites (103) . In vivo, SPOl is not subject to restriction and modification in cells of the B. subtilis strain R; possibly the existing five BsuRI sites are protected by an additional antirestriction mechanism (103) .
The DNA of the coliphage T7 also contains surprisingly few cleavage sites for a number of restriction enzymes (109) . On the other hand, there are unexpectedly numerous EcoPl sites (75) , which might be explained by the fact that the EcoPl recognition sequence (4) Phage T5 DNA enters the host cell in two steps that are referred to as first-step (8% of genome) and second-step (rest of genome) transfer DNA. Intracellular expression of the firststep transfer genes is the precondition for injection of the rest of the T5 genome (for a review on phage T5, see reference 89). T5 is not restricted in host cells carrying the EcoK, EcoPl, or EcoRI DNA host specificity systems (21, 34) . However, the T5 DNA possesses recognition sites at least for the EcoRI enzyme; the DNA is sensitive to EcoRI digestion in vitro, and six EcoRI sites were located in the second-step transfer DNA (36, 107) .
The protection of T5 DNA against EcoRI restriction in vivo was studied in more detail (15, 21, 22) . Indirect evidence led to the conclusion that a gene in the first-step transfer DNA of T5 determines an antirestriction mechanism (the nature of which is unknown). T5 mutants were isolated which are restricted in cells with an active EcoRI system. These mutants, called ris, were still resistant to EcoK and EcoPl. The Ris phenotype was not due to mutation in an antirestriction gene, but rather to the acquisition of new EcoRI sites at different positions in the firststep transfer DNA (15) . When cells are infected by T5 the proposed antirestriction activity is expressed early enough to protect the six EcoRI sites in the second-step transfer DNA, but a newly acquired EcoRI site within the first-step transfer DNA of ris mutants cannot be protected.
Brunel and Davison believe that mutants in the protection gene itself are inviable because of other essential functions of this gene (15) . This would explain why T5 can be made sensitive to EcoRI restriction only by the creation of new EcoRI sites within the nonprotected first-step transfer DNA. T5 mutants sensitive to the EcoPl restriction system were also announced (22) , but no further details have been published.
Male-Specific Single-Stranded DNA Phages The filamentous, single-stranded DNA phages of E. coli, of which fd and M13 are the best known examples, replicate in cells as doublestranded, plasmid-like DNA molecules, but a single strand only is incorporated into phage particles (86) . These phages are restricted normally in cells harboring type I and II restriction enzymes, but in vivo they are extremely resistant to the action of type III enzymes even though the double-stranded, replicative form of DNA is a good substrate for the enzymes in vitro (100) . Restriction by the type III enzymes is so poor that in the first review to describe the effects of restriction on a wide variety of different phages, they were listed as being unrestricted (11). We do not know the basis for the resistance of these phages to type III restriction systems. Some possibilities can, however, be eliminated. The lack of restriction is not due to a lack of recognition sites for the enzymes; fd, for example has five sites for EcoPl and two for EcoP15 (6) and yet is only restricted by a factor of three by EcoPl and undetectably by EcoP15 (10) . This is to be compared with the more than 1,000-fold restriction by the type I enzyme EcoB, which also has two sites on the fd genome (116) . Again, the resistance is not due to modifi- Preinfection of B. subtilis expressing the BsuM restriction system with phage SP18 protects superinfecting SP10 against restriction. The mechanism of the protection is unclear; however, it operates even when RNA or protein synthesis is blocked during the preinfection with SP18 (131) . So far as we know, the question of whether SP18 and Sno have partial DNA sequence homologies has not been investigated. If they did, the protective mechanism previously described for B. subtilis transfection and transformation might be operating. This mechanism protects unmodified DNA entering the cell from restriction, provided that homologous DNA sequences are already present (12, 17 The writing of this review and work from the laboratory of T.A.B. were supported by grants from the Swiss National Science Foundation.
